Using ultrasound to guide treatment decisions for rheumatoid arthritis
Official title: Ultrasound to Guide Treatment Decisions in Patients With Rheumatoid Arthritis According to a T2T Approach
Run by Italian Society for Rheumatology · NCT05717179 · Data updated 2026-11-12
This study is testing if using ultrasound to help make treatment choices can be just as good as regular methods for people with rheumatoid arthritis who are still having symptoms despite their current treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 84 Years |
| Sex | All |
| Enrollment | 158 (estimated) |
| Sponsor | Italian Society for Rheumatology Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (Bruneck, Bolzano) |
| Status | Recruiting |
| Started | February 22, 2023 |
| Main results expected | August 2028 |
| Study ends | February 2029 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT05717179 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 84 with moderate or high disease activity in rheumatoid arthritis and a maximum of two swollen joints.
✕Probably not a fit
Patients with complete joint destruction or those with active systemic manifestations of rheumatoid arthritis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of using ultrasound to guide treatment decisions in patients with rheumatoid arthritis (RA) who have moderate to high disease activity despite existing therapies. It is a randomized multicenter study comparing ultrasound-guided treatment decisions to standard clinical decision-making. The primary goal is to determine if the ultrasound approach is non-inferior in helping patients achieve low disease activity or remission within 24 weeks. Eligible participants include those with specific disease activity levels and treatment histories.
Why it matters
Potential benefit: If successful, this approach could lead to improved treatment outcomes for patients with rheumatoid arthritis.
How similar studies have gone: Other studies have shown promise in using ultrasound for treatment decisions in rheumatoid arthritis, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Classification of RA according to the ACR-EULAR 2010 criteria 2. Age of the patients: 18 to 84 years 3. Patients with moderate or high disease activity according to CDAI (\>10) 4. Maximum of 2 clinically swollen joints out of a 44-joint count 5. Current stable treatment with a single csDMARD or bDMARD or tsDMARD for at least 3 months 6. No glucocorticoid therapy or stable glucocorticoid dose for at least 4 weeks and at a maximum dose of 5 mg/day prednisone equivalent. 7. No corticosteroid intraarticular injection within 4 weeks 8. Stable or absent dose of NSAIDs for at least 1 week 9. Patients able and willing to give written informed consent and compliant with the requirements of the study protocol Exclusion Criteria: 1. Complete (clinically evident) destruction of any joint to be investigated by ultrasound as judged by the physician 2. Current RA-related vasculitis or other active systemic (i.e. extraarticular) RA-manifestation except for rheumatoid nodules, which in the opinion of the investigator would expose the study subject to a high risk of morbidity or mortality 3. Initial arthritis manifestations before the age of 18 years 4. Planned surgery within the study period for any of the joints investigated either clinically or by sonography 5. Current severe medical illness requiring hospitalization 6. Active infection or active malignancy at screening \<5 years 7. Any contraindication to b/ts DMARDs according to the "Summary of Product Characteristics" 8. Pregnancy or lactation
Where it's running
-
Azienda Sanitaria dell'Alto Adige
Bruneck, Bolzano, Italy Recruiting
Study contacts
- Study coordinator: Christian Dejaco, MD, PhD
- Email: Christian.Dejaco@sabes.it
- Phone: +390474581862
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-guided nasal bone fracture reduction
This study tests whether using ultrasound to guide nasal bone fracture reduction can improve accuracy and outcomes for people with recent nasal injuries.
-
Collarless Actis hip stem for cementless hip replacement in Asian patients
This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.
-
Inter-rater Test of Rectus Abdominis Thickness on Ultrasound After BFR Training
This study checks if different readers measure the thickness of the rectus abdominis on ultrasound the same way after a blood flow restriction workout.
-
Transoral and neck ultrasound to find suspected oropharyngeal (throat) cancers
This study will test whether adding transoral and neck ultrasound to the usual diagnostic tests helps doctors find oropharyngeal (throat) cancers more accurately in adults referred for suspicion of oropharyngeal cancer.
-
How the core and shoulder function relate in people with chronic low back pain
This study tests whether core stability and Transversus Abdominis (TrA) involvement affect upper body reach and scapular control in adults with chronic low back pain compared with healthy individuals.
-
Teaching anesthesiologists ultrasound-assisted neuraxial access for spinal anesthesia
This trial will test whether training anesthesiologists to use ultrasound for spinal anesthesia improves clinical outcomes and patient satisfaction for adults having elective lower limb surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.